Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at USA.gov.
The NHLBI Annual Sickle Cell Disease Clinical Research Meetings provide a yearly forum for investigators, practitioners, and interested health care providers to discuss the progress of ongoing clinical trials, hear presentations about new developments in scientific and clinical aspects of SCD, and interact with other investigators and NHLBI Program Staff.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health will participate in the 59th American Society of Hematology (ASH) Annual Meeting. NHLBI-supported research will be presented at more than 40 sessions. See the schedule below for a snapshot of the NHLBI’s sessions at 59th ASH Annual Meeting.
The National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) will participate in the 2017 American Heart Association (AHA) Scientific Sessions from November 11 to 15, 2017 in Anaheim, California. NHLBI research and NHLBI-funded research will be presented at more than 50 sessions. See the schedule below for a snapshot of the NHLBI’s sessions at AHA 2017. The schedule is subject to change.
The 2017 NIH Innovation Conference will provide investment-ready small businesses funded by NIH with pitch coaching and networking with experienced life science business professionals to prepare them for the Life Sciences Summit the following day.
SCiF is a two-day, intensive, educational update on sickle cell disease. The 11th annual SCiF conference will be co-hosted by the National Heart, Lung, and Blood Institute and The University of West Indies.
This conference will bring together leading experts in the field to discuss cutting-edge research in five key areas of systems biology: single-cell epigenomics, imaging-based systems biology, quantitative and integrative proteomics, systems biology of metabolism and large-scale data integration.
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodeling and inflammation, vascular remodeling and inflammation, and tissue engineering/genome editing/new technologies.
The National Heart, Lung, and Blood Institute (NHLBI) convened a Working Group meeting on September 21-22, 2017 in Bethesda, MD to assess the latest research findings in heart failure with preserved ejection fraction (HFpEF); identify research gaps and barriers that are specific to HFpEF; discuss emerging research methodologies on how best to address the identified knowledge gaps and barriers; and develop recommendations for research directions in HFpEF for the next 5-10 years. The Working Group consisted of leading experts in heart failure, HFpEF, and related fields.
The National Heart, Lung, and Blood Institute (NHLBI), with support from the Office of Behavioral and Social Science Research (OBSSR), convened a two-day workshop in Bethesda, MD on research challenges and opportunities in cardiovascular health of young adults (age 18-40 years).
Join NHLBI experts and a clinical trial participant as we discuss the latest in sickle cell disease research. Tune in to our Facebook page on the day of the event to join the conversation and have your questions answered live.